What does CUSIP M96088105 represent in this 13F holders report?

CUSIP M96088105 is the security identifier for URGN - UroGen Pharma Ltd. - Common Stock used to aggregate holder disclosures.

How many institutions held URGN - UroGen Pharma Ltd. - Common Stock in Q1 2020?

78 institutional investors reported URGN - UroGen Pharma Ltd. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

UroGen Pharma Ltd. - Common Stock (URGN)

CUSIP: M96088105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 48,457,135
Total 13F shares: 13,991,634
Share change: -337,753
Total reported value: $249,248,555
Put/Call ratio: 70%
Price per share: $17.84
Number of holders: 78
Value change: -$10,038,151
Number of buys: 32
Number of sells: 42

Quarterly Holders Quick Answers

What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP M96088105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MENORA MIVTACHIM HOLDINGS LTD.	13F	Company	6.1%	2,954,699	$98,598,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	2.8%	1,372,863	$45,811,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.5%	1,221,397	$40,759,000	—	31 Dec 2019	13F
Wildcat Capital Management, LLC	13F	Company	2.4%	1,155,862	$38,571,000	—	31 Dec 2019	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	1.8%	849,478	$28,347,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	1.7%	831,488	$27,747,000	—	31 Dec 2019	13F
Phoenix Financial Ltd.	13F	Company	1.7%	834,739	$27,663,000	—	31 Dec 2019	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	1.5%	738,302	$24,637,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	1.4%	669,435	$22,339,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.85%	411,694	$13,738,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.65%	314,603	$10,498,000	—	31 Dec 2019	13F
MEITAV INVESTMENT HOUSE LTD	13F	Company	0.56%	272,063	$9,080,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.47%	227,763	$7,600,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.46%	222,024	$7,409,000	—	31 Dec 2019	13F
Prosight Management, LP	13F	Company	0.45%	217,686	$7,264,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.3%	143,942	$4,803,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	122,544	$4,089,000	—	31 Dec 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.25%	120,042	$4,005,000	—	31 Dec 2019	13F
Horton Capital Management, LLC	13F	Company	0.22%	108,670	$3,626,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.21%	102,445	$3,419,000	—	31 Dec 2019	13F
ROYAL BANK OF CANADA	13F	Company	0.21%	102,143	$3,409,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.19%	93,975	$3,136,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	0.17%	80,589	$2,690,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.15%	73,683	$2,459,000	—	31 Dec 2019	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.14%	67,025	$2,237,000	—	31 Dec 2019	13F
SG Americas Securities, LLC	13F	Company	0.1%	50,340	$1,680,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.1%	48,235	$1,610,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	46,717	$1,559,000	—	31 Dec 2019	13F
ALPS ADVISORS INC	13F	Company	0.09%	42,590	$1,421,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.08%	40,354	$1,347,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.07%	35,900	$1,198,000	—	31 Dec 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.07%	34,466	$1,150,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.07%	34,000	$1,135,000	—	31 Dec 2019	13F
JANE STREET GROUP, LLC	13F	Company	0.07%	31,719	$1,058,000	—	31 Dec 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	28,100	$938,000	—	31 Dec 2019	13F
GROUP ONE TRADING LLC	13F	Company	0.06%	28,096	$938,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.06%	28,009	$935,000	—	31 Dec 2019	13F
Altshuler Shaham Ltd	13F	Company	0.05%	26,172	$873,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	23,405	$781,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	21,900	$731,000	—	31 Dec 2019	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.04%	21,494	$731,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.05%	21,860	$730,000	—	31 Dec 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.04%	20,957	$699,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.04%	19,753	$660,000	—	31 Dec 2019	13F
Coastal Bridge Advisors, LLC	13F	Company	0.04%	19,692	$657,000	—	31 Dec 2019	13F
BANK HAPOALIM BM	13F	Company	0.04%	17,055	$569,000	—	31 Dec 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.03%	16,401	$547,301	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	16,300	$544,000	—	31 Dec 2019	13F
ARK Investment Management LLC	13F	Company	0.03%	16,025	$535,000	—	31 Dec 2019	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	0.04%	17,666	$529,388	—	31 Dec 2019	13F

Institutional Holders of UroGen Pharma Ltd. - Common Stock (URGN) as of Q1 2020

As of 31 Mar 2020, UroGen Pharma Ltd. - Common Stock (URGN) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,991,634 shares. The largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Wildcat Capital Management, LLC, Phoenix Holdings Ltd., Migdal Insurance & Financial Holdings Ltd., BAKER BROS. ADVISORS LP, CREDIT SUISSE AG/, Clal Insurance Enterprises Holdings Ltd, and STATE STREET CORP. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

-7

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.